Skip to main content
Clinical Trials/ACTRN12609000996268
ACTRN12609000996268CompletedPhase 4

Randomized prospective trial of cyclosporine with/without low-dose prednisolone in idiopathic membranous nephropathy in adults with nephrotic syndrome

Research Group for Treatments of Kidney Diseases in Ibaraki, Japan0 sites30 target enrollmentStarted: March 31, 2006Last updated:

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
30

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Blinded (masking used)

Eligibility Criteria

Ages
16 Years to 80 Years (—)
Sex
All

Inclusion Criteria

  • Biopsy proven idiopathic membranous nephropathy.
  • Over 3.5 g/day of excretion of urinary protein.

Exclusion Criteria

  • Secondary forms of membranous nephropathy.
  • Less than 70 ml/min of creatinine clearance.
  • Patients with relapse or recurrence.
  • Treated with other immunosuppressants.

Investigators

Sponsor
Research Group for Treatments of Kidney Diseases in Ibaraki, Japan

Similar Trials